Novo Nordisk Foundation
Challenge Programme 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections
14:00 Copenhagen time
Last updated:
The Novo Nordisk Foundation Challenge Programme 2027 funds consortia of established research leaders to develop next-generation diagnostics for antibiotic-resistant pathogens in lower respiratory tract infections, with grants of €4-10 million over six years. The call is open internationally to researchers in EU, Switzerland, Norway, Iceland, and the UK working on innovative solutions aligned with the foundation's strategic priorities. This is a one-off, high-ambition call requiring coordinated research partnerships with a shared vision.
Details
| Funder | Novo Nordisk Foundation |
| Budget | DKK 30-75 million per grant |
| Deadline | 7 October 2026 |
| Duration | 6 years |
| Consortium | Required — leading researchers forming a consortium united by a clear vision and mission |
| Application | 2-stage: Stage 1 results December 2026, Stage 2 results June 2027 |
| Frequency | Annual |
| Eligible countries | DK |
Recently updated
catalog cleanup 2026-07-04: Oct date was not the published Stage-1 deadline per NNF
Eligibility & scope
Funds consortia of leading researchers to develop next-generation AMR diagnostics for lower respiratory tract infections, targeting research leaders (established/professor level) within Danish and European research ecosystems. International location; research area focus is infectious diseases.
Who Should Apply
- •Established and professor-level research leaders with track records in diagnostics or antimicrobial resistance
- •Consortia spanning research institutions in eligible countries (EU, Switzerland, Norway, Iceland, UK)
- •Projects addressing lower respiratory tract infections caused by antibiotic-resistant organisms
- •Teams with a clearly articulated shared vision and complementary expertise
Key Dates
- •Deadline 7 October 2026, 2:00pm Copenhagen time
- •Two-stage review: Stage 1 results December 2026, Stage 2 results June 2027
- •Six-year project duration
Tips for Applicants
- ✓Consortium quality is gating, articulate the added value of each partner and their specific roles; generic consortia score poorly.
- ✓The challenge framing must align visibly with Novo Nordisk Foundation's strategic priorities; review their published strategy before writing.
- ✓Stage 1 should be a tight, visionary 10-15 page outline; avoid detailed methods, reviewers screen for ambition and feasibility at Stage 1, not experimental granularity.
Frequently Asked Questions
How much funding does the Novo Nordisk Foundation Challenge Programme 2027 award?
Grants range from €4 million to €10 million (DKK 30-75 million) over six years per consortium.
Who can apply to the Challenge Programme 2027?
Established and professor-level research leaders based in the EU, Switzerland, Norway, Iceland, or the UK, applying as consortia.
Is the Challenge Programme 2027 recurring?
No, this is a one-off call with a single deadline in October 2026.
What is the deadline for the Challenge Programme 2027?
7 October 2026 at 2:00pm Copenhagen time, with Stage 1 results in December 2026 and Stage 2 results in June 2027.
Must applicants form a consortium?
Yes, the call requires a consortium of research partners with a clear shared vision and mission.
Related on Grantsby
- Novo Nordisk Foundation Challenge Programme, full programme guide
Eligibility, budget, success rates, application timeline, FAQ.
- Novo Nordisk Foundation Challenge Programme past winners & funded projects
Recent recipients, host institutions, and funded project titles. See who tends to win before you apply.
Summary generated by AI based on published grant information. Always verify details on the funder's website.
Similar grants
Challenge Programme
Novo Nordisk FoundationDeadline: 7 Oct 2026DKK 30-75 million per grantChallenge Programme 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections
Novo Nordisk FoundationDKK 30–75 million (ca. EUR 4–10 million)OHAMR Research Call on New Treatments to Tackle AMR
SNSFJpi Amr
SNSFTandem Programme – Translational research collaboration between Basic and Clinical Researchers
Novo Nordisk FoundationDeadline: 21 Jan 2027Up to DKK 13M per grant
Browse Related
Could Challenge Programme 2027 – Advancing Next Generation AMR Diagnostics for Lower Respiratory Tract Infections be right for you?
Deadline in 24 days. See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.
See my matches free →